Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection.
Human alpha-defensins are evolutionarily conserved effectors of the innate immune response with broadly acting antibacterial activity. Their role in antiviral immunity is less well understood. We previously showed that these antimicrobial peptides are potent inhibitors of human adenovirus infection. Based on biochemical studies and indirect evidence from confocal microscopy, we proposed that defensins bind to and stabilize the virus capsid and neutralize infection by preventing the release of the endosomalytic protein VI. To determine whether defensin action also restricts exposure of the viral genome, we developed a system to evaluate adenovirus uncoating during cell entry by monitoring the exposure of BrdU-labeled viral genomes. This assay allowed us to determine the kinetics of uncoating of virus particles in single cells. Using this assay, we now provide direct evidence that human alpha-defensins block adenovirus infection by preventing uncoating during cell entry.
10550 N. Torrey Pines Rd., IMM19, La Jolla, CA 92037, USA.
Emily K
EK
Nguyen
Glen R
GR
Nemerow
Jason G
JG
Smith
D000257:Adenoviridae Infections / Q000276:immunology*; D000260:Adenoviruses, Human / Q000276:immunology* / Q000502:physiology*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002213:Capsid / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D018613:Microscopy, Confocal; D013194:Staining and Labeling / Q000379:methods; D014764:Viral Proteins / Q000378:metabolism; D053586:Virus Internalization; D023084:alpha-Defensins / Q000276:immunology*
C500225:DEFA5 protein, human; D014764:Viral Proteins; D023084:alpha-Defensins; D001973:Bromodeoxyuridine